Penumbra, Inc. Sets Date for First Quarter 2025 Earnings Release
Penumbra, Inc. (NYSE: PEN) is preparing to host a conference call to share financial results for the first quarter of 2025. The call will take place shortly after the market closes on Wednesday, April 23, 2025. With analysts eagerly awaiting insights into the company’s performance, a press release detailing these financial results will also be published on the same day.
Accessing the Conference Call
The conference call can be joined by phone at (888) 596-4144, using the conference ID 6572573. For those who prefer to listen online, the webcast will be available in the "Events and Presentations" section under the "Investors" tab on the company's website. Following the call, the webcast will remain accessible for a minimum of two weeks, ensuring that interested parties can catch up on what they missed.
About Penumbra, Inc.
Penumbra, Inc. stands as a leader in thrombectomy technology, dedicated to developing cutting-edge solutions for complex medical challenges such as ischemic stroke and venous thromboembolism. Their innovative products include computer-assisted vacuum thrombectomy (CAVT), which allows for the efficient removal of blood clots from patients. This technology is designed with safety and speed in mind, catering to healthcare professionals and improving outcomes for patients worldwide.
Impact on Healthcare
The company's reach extends to over 100 countries, collaborating with healthcare providers, hospitals, and clinics. By providing advanced medical devices and support, Penumbra strives to enhance the quality of life for patients facing serious health conditions. Their commitment to innovation reflects a deep understanding of the complexities involved in medical care.
Connecting with Penumbra
For those interested in learning more about Penumbra, Inc., their official website hosts a wealth of information about their products, innovations, and mission. Additionally, Penumbra maintains a vibrant presence on social media platforms such as Instagram, LinkedIn, and X, allowing followers to stay updated on the latest developments within the company.
Investor Relations
For inquiries regarding investor relations, individuals can reach out directly to Penumbra. The organization's transparency and dedication to their stakeholders are evident in their communication, ensuring that investors are kept informed about performance and prospects.
Frequently Asked Questions
What is the date for Penumbra, Inc.'s first quarter 2025 earnings call?
The conference call is scheduled for April 23, 2025, after market close.
How can I access the conference call?
You can join the call by dialing (888) 596-4144 and using conference ID 6572573, or listen via the webcast on the company’s website.
What technologies does Penumbra, Inc. focus on?
Penumbra focuses on innovative medical technologies for conditions such as ischemic stroke and venous thromboembolism.
In how many countries does Penumbra operate?
Penumbra operates in over 100 countries globally, providing medical devices and support.
Where can I find more information about Penumbra?
Visit Penumbra’s official website or follow them on social media platforms for the latest updates and information.
